BioMarin Pharmaceuticals BMRN Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from BioMarin Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The official record: BioMarin Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioMarin Pharmaceuticals's quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioMarin Pharmaceuticals's quick ratio?
- BioMarin Pharmaceuticals (BMRN) reported quick ratio of 4.2× in Q1 2026.
- How has BioMarin Pharmaceuticals's quick ratio changed year-over-year?
- BioMarin Pharmaceuticals's quick ratio increased by 20.3% year-over-year, from 3.5× to 4.2×.
- What is the long-term trend for BioMarin Pharmaceuticals's quick ratio?
- Over 5 years (2020 to 2025), BioMarin Pharmaceuticals's quick ratio has grown at a 0.9% compound annual growth rate (CAGR), from 3.3× to 3.5×.
- What does quick ratio mean?
- Can the company cover short-term bills without having to sell inventory first?
- How do you interpret quick ratio?
- More conservative than the current ratio. A wide gap between the two flags heavy reliance on inventory to meet near-term obligations.
- How does quick ratio compare across companies?
- Most informative for inventory-heavy businesses; converges with the current ratio for firms that carry little inventory.